Lupin Limited has informed the Exchange regarding a press release dated March 17, 2026, titled "Lupin and Zydus Sign Licensing Agreement for Co-marketing Innovative Semaglutide Injection in India".
Lupin Limited has informed the Exchange regarding a press release dated March 17, 2026, titled "Lupin and Zydus Sign Licensing Agreement for Co-marketing Innovative Semaglutide Injection in India".